Recherchiere Firmenbekanntmachungen und finanzielle Kennzahlen
UK-Förderung (88.229 £): Enzyme co-localisation and aggregation for enhanced metabolic activity for commodity chemicals. Ukri01.09.2016 Forschung und Innovation im Vereinigten Königreich, Großbritannien
Auf einen Blick
Text
Enzyme co-localisation and aggregation for enhanced metabolic activity for commodity chemicals.
| Zusammenfassung | Current approaches for enhancing bio-based commodity production are restricted to known biosynthetic pathways and limitations to metabolite toxicity. However, many key bio-commodities are made via aldehyde-intermediates such as acetaldehyde, lactaldehyde and propanaldehyde and their production is often limited because of the inherent toxicity of their chemical reactivity. Ways to reduce this toxicity would offer a significant advantage to the commercial production of these materials. This application outlines a major new strategy to reduce the toxicity of key metabolic intermediates such as acetaldehyde through the deployment of proteinaceous scaffolds. This approach will be coupled to a novel pathway that will be engineered in specific bacteria called acetogens that can live on gaseous exhaust fumes in order to produce a key chemical commodity called 1,3-butanediol. |
| Kategorie | Feasibility Studies |
| Referenz | 132326 |
| Status | Closed |
| Laufzeit von | 01.09.2016 |
| Laufzeit bis | 30.11.2017 |
| Fördersumme | 88.229,00 £ |
| Quelle | https://gtr.ukri.org/projects?ref=132326 |
Beteiligte Organisationen
| Zuvasyntha Limited |
88.229,00 £ |
| University of Kent |
Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider. Der aktuelle Stand wird auf folgender Seite wiedergegeben: Zuvasyntha Ltd., Knebworth, Großbritannien.
Die Visualisierungen zu "Zuvasyntha Ltd. - UK-Förderung (88.229 £): Enzyme co-localisation and aggregation for enhanced metabolic activity for commodity chemicals."
werden von
North Data
zur Weiterverwendung unter einer
Creative Commons Lizenz
zur Verfügung gestellt.
